Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet P Hapgood

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Steroids|June 7, 2011
Differential nuclear localisation and promoter occupancy play a role in glucocorticoid receptor ligand-specific transcriptional responsesKatie E Hadley, Ann Louw, Janet P Hapgood
Pharmacology & Therapeutics|June 12, 2016
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapyJanet P Hapgood, Chanel Avenant, Johnson M Moliki
The Journal of Biological Chemistry|September 10, 2014
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent mannerRenate Louw-du Toit, Janet P Hapgood, Donita Africander
Biochemical and Biophysical Research Communications|April 3, 2020
A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptorRenate Louw-du Toit, Janet P Hapgood, Donita Africander
Trends in Pharmacological Sciences|October 20, 2004
Not all progestins are the same: implications for usageJanet P Hapgood, Dominique Koubovec, Ann Louw, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 28, 2014
A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)Donita J Africander, Karl-Heinz Storbeck, Janet P Hapgood
Plos One|May 30, 2013
Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture modelSteven Robertson, Johann M Rohwer, Janet P Hapgood, et al.
Endocrine Reviews|December 15, 2012
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsFrank Z Stanczyk, Janet P Hapgood, Sharon Winer, et al.
Contraception|December 16, 2017
Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Chelsea B Polis, Sharon L Achilles, Zdenek Hel, et al.
Molecular and Cellular Endocrinology|June 22, 2010
Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activityChanel Avenant, Katharina Ronacher, Elisabeth Stubsrud, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Steroids|June 7, 2011
Differential nuclear localisation and promoter occupancy play a role in glucocorticoid receptor ligand-specific transcriptional responsesKatie E Hadley, Ann Louw, Janet P Hapgood
Pharmacology & Therapeutics|June 12, 2016
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapyJanet P Hapgood, Chanel Avenant, Johnson M Moliki
The Journal of Biological Chemistry|September 10, 2014
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent mannerRenate Louw-du Toit, Janet P Hapgood, Donita Africander
Biochemical and Biophysical Research Communications|April 3, 2020
A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptorRenate Louw-du Toit, Janet P Hapgood, Donita Africander
Trends in Pharmacological Sciences|October 20, 2004
Not all progestins are the same: implications for usageJanet P Hapgood, Dominique Koubovec, Ann Louw, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 28, 2014
A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)Donita J Africander, Karl-Heinz Storbeck, Janet P Hapgood
Plos One|May 30, 2013
Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture modelSteven Robertson, Johann M Rohwer, Janet P Hapgood, et al.
Endocrine Reviews|December 15, 2012
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsFrank Z Stanczyk, Janet P Hapgood, Sharon Winer, et al.
Contraception|December 16, 2017
Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Chelsea B Polis, Sharon L Achilles, Zdenek Hel, et al.
Molecular and Cellular Endocrinology|June 22, 2010
Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activityChanel Avenant, Katharina Ronacher, Elisabeth Stubsrud, et al.
Pageof 5